FiercePharma

Alcon receives FDA approval of Pazeo(TM) Solution for ocular allergy itch relief

US Food and Drug Administration grants approval of Pazeo(TM) (olopatadine hydrochloride ophthalmic solution) 0.7% for sale in the United States Developed with efficacy data at 24 hours, post dose, to ...
Houston Chronicle

(BW) Alcon's VEGAMOX(TM) Ophthalmic Solution Approved in Japan for Eye Infections

FORT WORTH, Texas--(BUSINESS WIRE)--July 26, 2006--Alcon, Inc. (NYSE:ACL) announced today that the Ministry of Health, Labor and Welfare in Japan has approved its VEGAMOX(TM) (moxifloxacin ...
Nasdaq

United Therapeutics Announces FDA Approval Of XPS(TM) And Steen Solution(TM) Used To Perform Centralized Ex-Vivo Lung Perfusion Services

SILVER SPRING, Md., April 29, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced that its collaborator, XVIVO Perfusion, Inc., a subsidiary of XVIVO Perfusion AB (STO: ...
FierceBiotech

Allergan Receives FDA Approval for ZYMAXID(TM) Ophthalmic Solution

IRVINE, Calif., May 19, 2010 (BUSINESS WIRE) -- Allergan, Inc. today announced that the United States Food and Drug Administration (FDA) has approved ZYMAXID(TM) (gatifloxacin ophthalmic solution) 0.5 ...